Valeo Pharma Immune Booster Now Available In ~300 Stores Under Loblaws Banner, Another Step Closer to 2025 Revenue Target of $160M

Valeo Pharma is already a successful, revenue-generating, small-cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.

This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small-cap pharma companies.

The company released stellar a Q3 with the following highlights:

• Record revenues of $5.7 million for Q3 2021, up 280% over Q3 2020 and 114% over the prior quarter.
• Record gross margin of $2.2 million, up 1602% over Q3 2020 and 204% over the prior quarter.
• Record 9 months revenues at $10.2 million, up 94%

But wait, there’s more…

The company announced that Hesperco™ Is Now Available At Loblaws, Hesperidin Covid-19 Clinical Trial Results were Submitted For Publication.

• Approved by Health Canada for immune support, is now available for sale in approximately 300 stores under the Loblaw's banners including Loblaws
  Dominion,
  Zehrs,
  Fortinio's,
  Your Independent Grocer and Superstore
  

Steve Saviuk, CEO commented,

We are very pleased to announce that Hesperco is now available in over 300 Loblaw banner stores. The immune support properties of hesperidin, the sole medicinal ingredient contained in Hesperco capsules, have been well documented in numerous scientific publications. We are also encouraged by the results of the Hesperidin Covid-19 clinical trial which has recently been submitted for publication. The study concluded that hesperidin could have beneficial effects and may help reduce certain Covid-19 symptoms. The publication further suggested that earlier treatment of longer duration and/or higher dosage should be studied."

But wait, there’s more…

The company Closed Previously Announced Upsized $15 Million Bought Deal Private Placement And Concurrent $10 Million Private Placement with Investissement Québec.

Now sit back, relax and listen to this powerful interview with Valeo Pharma.